CD274 and neoplasm: Immunohistochemistry (IHC) can be a reliable tool to evaluate PD-L1 expression in tumor samples; however, the use of various clones of PD-L1 and lack of consistent cut-off values complicates comparison among studies for this biomarker [61, 64, 67].